ABMD
Abiomed Inc
ABMD
ABMD
Delisted
ABMD was delisted on the 21st of December, 2022.
514 hedge funds and large institutions have $10.5B invested in Abiomed Inc in 2022 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 189 increasing their positions, 174 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
514
Holders Change
+21
Holders Change %
+4.26%
% of All Funds
8.89%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
56
Increased
189
Reduced
174
Closed
31
Calls
$48.7M
Puts
$14.2M
Net Calls
+$34.5M
Net Calls Change
+$50.4M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$70.7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$64.7M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$58.4M |
| 4 |
Amundi
Paris,
France
|
+$20.3M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$19.4M |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$46.3M |
| 2 |
Renaissance Technologies
New York
|
-$44.4M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$29.3M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$27.3M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$20.9M |